Skip to main content

Table 1 clinical and laboratory features of patients with myeloid malignancies

From: GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignancies

Parameter

AML

CML

MDS

Age, median (range) (years)a

54(2-86)

52(11-75)

63(39-85)

Sex (male/female)

44/28

8/7

5/2

WBC (×109/l)a

7.5(0.3-203.6)

83.4(2.8-168.7)

3.6(1.6-12.2)

Haemoglobin (g/dl)a

71(24-123)

91(50-134)

64(46-91)

Platelet count (×109/l)a

40(3-447)

200(20-850)

50(10-926)

Cytogenetics

   

   Good

22

 

3

   Intermediate

35

 

3

   Poor

8

 

1

CD34(+/-)

35/26

  

GRAF levela

3.88(0.01-169.75)b

23.51(0.01-157.42)c

10.20(0.25-45.90)b

  1. WBC, white blood cells; aMedian (range); bP < 0.001, compared with control; cP = 0.030, compared with control;